Navigation and service

You are here:Rote-Hand-Briefe and Information Letters

Dear Doctor Letter (Rote-Hand-Brief) on Inhixa® (enoxaparin sodium): Risk of self-activation of the safety device in unopened, unused pre-filled syringes

Date 2018.04.18
Active substance enoxaparin sodium

The company Techdow Pharma Germany GmbH is circulating information on rare cases of premature self-activation of the safety device in unopened, unused pre-filled Inhixa syringes.